IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	86.34	83.81	73.24	65.56	53.3	41.81
Revenue Growth	11.21%	14.43%	11.71%	23.00%	27.47%	31.84%
Cost of Revenue	20.84	19.49	16.89	15.4	12.02	9.76
Gross Profit	65.5	64.32	56.35	50.16	41.28	32.05
Selling, General & Admin	34.88	35.23	31.59	27.3	23.41	20.36
Research & Development	3.06	2.95	2.8	2.82	2.24	1.87
Operating Expenses	37.94	38.18	34.39	30.12	25.65	22.23
Operating Income	27.56	26.15	21.97	20.04	15.63	9.82
Interest & Investment Income	2.01	2.01	2.19	1.86	0.58	0.03
Currency Exchange Gain (Loss)	0	0	-0.04	-0.15	-0.04	-0.03
Other Non Operating Income (Expenses)	-0.02	-	0.16	-	-	-
EBT Excluding Unusual Items	29.54	28.16	24.28	21.75	16.17	9.82
Gain (Loss) on Sale of Investments	-	-	-	-	0.01	0.02
Gain (Loss) on Sale of Assets	0.2	0.2	-0	-0.01	-	-
Pretax Income	29.75	28.36	24.28	21.74	16.18	9.84
Income Tax Expense	6.69	5.88	5.04	4.55	3.35	0.51
Net Income	23.06	22.48	19.23	17.19	12.83	9.33
Net Income to Common	23.06	22.48	19.23	17.19	12.83	9.33
Net Income Growth	11.61%	16.88%	11.87%	34.02%	37.56%	581.19%
Shares Outstanding (Basic)	13	13	13	13	13	12
Shares Outstanding (Diluted)	13	13	13	13	13	13
Shares Change	0.41%	0.55%	0.48%	0.69%	0.36%	1.21%
EPS (Basic)	1.81	1.77	1.52	1.36	1.02	0.76
EPS (Diluted)	1.79	1.75	1.50	1.35	1.02	0.74
EPS Growth	11.18%	16.67%	11.11%	32.35%	37.84%	572.73%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	25.12	17.18	17.62	6.02	9.22	10.78
Free Cash Flow Per Share	1.95	1.34	1.38	0.47	0.73	0.86
Dividend Per Share	0.770	0.710	0.470	0.150	-	-
Dividend Growth	16.67%	51.06%	213.33%	-	-	-
Gross Margin	75.86%	76.75%	76.94%	76.50%	77.45%	76.65%
Operating Margin	31.91%	31.20%	29.99%	30.56%	29.32%	23.48%
Profit Margin	26.70%	26.82%	26.26%	26.22%	24.07%	22.30%
Free Cash Flow Margin	29.09%	20.50%	24.06%	9.19%	17.30%	25.77%
EBITDA	29.18	27.31	22.78	20.8	16.3	11.22
EBITDA Margin	33.80%	32.59%	31.11%	31.73%	30.58%	26.84%
D&A For EBITDA	1.63	1.17	0.82	0.77	0.67	1.41
EBIT	27.56	26.15	21.97	20.04	15.63	9.82
EBIT Margin	31.91%	31.20%	29.99%	30.56%	29.32%	23.48%
Effective Tax Rate	22.49%	20.74%	20.77%	20.91%	20.72%	5.19%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error